Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:17 PM
Ignite Modification Date:
2025-12-24 @ 9:17 PM
NCT ID:
NCT04190004
Brief Summary:
The study investigates the effect of 40IU of intranasal vasopressin on cooperative behavior in patients with schizophrenia
Study:
NCT04190004
Study Brief:
Protocol Section:
NCT04190004